Kidney Transplant program
Thank you volunteers!
We would like to sincerely thank all of the patients who have helped us to explore new ideas and approaches to chronic kidney disease and kidney transplant over the years. We are constantly working to improve outcomes and the experience for patients with kidney disease.
Research program update
We are currently involved in research studies focusing on chronic kidney disease and kidney transplant. The kidney transplant study doctors, also known as study investigators, include Dr. Ramesh Prasad, Dr. Darren Yuen and Dr. Jeffrey Zaltzman. We have been working on an exciting group of studies this past year, along with some new studies that will be rolling out in the next few months. Below we have provided a basic introduction to some of the current types of studies in the Transplant Program. The studies are identified by their simple or short title.
DGF MRI study, DWI MRI study, RTF MRI study
The goal of these studies is to use information obtained by MRI (magentic resonance imaging) to help us understand kidney damage related to scarring or fibrosis.
Cross-sectional studies: AMINODAT study, ANEMIAT study
The goal of these studies is to look for unique laboratory biomarkers at a single study visit that may help us to better understand diabetes and anemia after kidney transplantation.
Prospective studies: UHN QFT CMV studyThe goal of this study is to see if a specific lab test that is drawn at different study visits can help guide medical decisions related to CMV prophylaxis medications after kidney transplant. Cytomegalovirus or CMV is a common cause of infection in patients who have undergone a transplant.
UHN LDKT Study
The goal of this study is to help learn more about potential barriers to living donation using questionnaires completed at different points in time in the transplant work-up process.
REGIFT study, ZOSTER 041 study, FKC014 study, BK KIDNI study
Clinical trials use formal, organized research methods to learn more about a topic, and allow conclusions to be made about a topic by comparing different groups in a controlled way. The goal of clinical trials includes testing new medications in development to see how well they work and to see if they are safe.
Patient research contact list
If you would like to receive information directly from the research team about upcoming studies, let any of the clinical program staff know or feel free to contact the kidney research team directly at the numbers listed below. Signing up for the research contact list does not mean that you are agreeing to participate in any studies - it just means that you agree to receive information about research directly from the research team. This is entirely voluntary and you can remove your name from the research contact list at any time. You will also be able to learn about research opportunities from your clinical team, ads in the waiting room and patient publications (i.e. newsletter).
|St. Michael’s Hospital Kidney Research Team|
|Research manager||Michelle Nashemail@example.com|
|Research coordinator||Lindita Rapi||416-867-7460 ext firstname.lastname@example.org|
|Research unit coordinator||Niki Dacouris||416-864-6060 ext email@example.com|
|Research assistant||Weiqiu Yuan||416-867-7460 ext firstname.lastname@example.org|
Patient oriented research
We are working to find ways to involve patients in the research process and to get information that has been learned from research back to the kidney transplant patient community. We would also like to get feedback on what we are doing well, and what we could improve within the research program.
We’re planning to post more information about studies that are currently active as well as to post links to articles that have been published by our team.
If you have any ideas for research, for this webpage, any suggestions for general improvement or would be interested in being contacted for your feedback on different initiatives as they are developed, please contact Michelle Nash at 416-867-3692 or email@example.com.